AzTrials
AzTrials

Spinal AnesthesiaNCT06048497

The Role of Carotid Flow Time-Based Fluid Administration in Caesarean Section

An observational study of Spinal Anesthesia and Cesarean Section, run by Cukurova University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It has been reported that corrected carotid flow time (FTc) may indicate the responsiveness of spontaneously breathing patients to fluid therapy. The primary objective of the study is to determine the effect of fluid preload applied to patients with preanesthetic FTc values below the cut-off value on the incidence of… Read more about this study

Who is it for?
Ages 20 to 40 years, women only
Conditions the study is for
Spinal Anesthesia, Cesarean Section
What is being tested?
Corrected carotid flow time measurement guided fluid preload
Type of treatment
Medical device
How many people
72 participants
Where
2 sitesTurkey (Türkiye)
Study dates
15 Nov 2022to 5 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: ASA II pregnant women between the ages of 20 and 40 who were undergoing elective cesarean section, and had uncomplicated singleton term pregnancies, and agreed to participate in the study were included.

Who may be able to join

  • 20-40 years of age pregnant women
  • American Society of Anesthesiologists (ASA) physical status-II patients
  • Uncomplicated, singleton, term pregnancy
  • Elective C/S surgery

Who cannot join

  • Placental disorders
  • Gestational hypertensive disorders
  • Morbid obesity (BMI>39 kg/m2)
  • Carotid stenosis more than 50%
  • Baseline SAP more than 160 mmHg
  • Arrhythmia
  • History of cardiovascular or cerebrovascular disease, and chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m2)
  • Emergency surgery

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Cukurova University

    Adana, Saricam, 01330

  • Çukurova University; Faculty of Medicine

    Adana, Sarıçam, 01330

Other trials in Turkey (Türkiye)

About this study

Official title: The Role of Carotid Flow Time-Based Fluid Administration in the Incidence of Hypotension After Spinal Anesthesia in Patients Undergoing Caesarean Section

It has been reported that corrected carotid flow time (FTc) may indicate the responsiveness of spontaneously breathing patients to fluid therapy. The primary objective of the study is to determine the effect of fluid preload applied to patients with preanesthetic FTc values below the cut-off value on the incidence of hypotension in cesarean section (C/S) surgery. Pregnant women who underwent cesarean section under spinal anesthesia were included in this prospective study. In the preoperative care unit, patients were assigned to two groups according to their baseline FTc values. Patients with baseline FTc < 327 ms were assigned to the first group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc > 327 ms. On the other hand, patients with baseline FTc > 327 ms were assigned to the second group, and preload fluid was not administered to these patients. Intraoperative hemodynamic data were recorded for each patient.

Being tested
Corrected carotid flow time measurement guided fluid preload
Keywords
Cesarean section, Carotid flow time, Preload fluid, Hypotension, Spinal anesthesia
Medical subject headings
Hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Corrected carotid flow time measurement guided fluid preloadDevice

    Preoperative FTcs of pregnant women who underwent C/S operation were measured, and those below the cut-off value (327 ms) determined in previous studies were preloaded with Ringer Lactate until FTc was > 327 ms.

Study groups in NCT06048497
Study groupRoleWhat they receive
PreloadPatients with baseline FTc < 327 ms were assigned to the preload group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc > 327 ms.
Receives: Device: Corrected carotid flow time measurement guided fluid preload
Non-preloadPatients with baseline FTc > 327 ms were assigned to the non-preload group, and preload fluid was not administered to these patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of intra-operative hypotension

    Hypotension definitions included systolic arterial pressure (SAP) below 80 mmHg, or mean arterial pressure (MAP) below 65 mmHg, or a decrease in SAP of more than 30% below baseline, or a decrease in MAP of more than 20% below baseline, or any combination of all these definitions.

    Measured: During surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2023
  2. Study start15 Nov 2022
  3. Primary completion20 May 2023
  4. Study completion5 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06048497
Sponsor's protocol ID
FTCCS
Status last verified
Sep 2023
First submitted
15 Sep 2023
Last updated
28 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All data were anonymized by the local researcher. Therefore, data collection was pseudonymous and the patient's name did not appear on any case report form or other study document. All collected data were kept confidential. This study was conducted in accordance with the revision of the Declaration of Helsinki (2008). International Conference on Harmonisation-Good Clinical Practice (ICH-GCP) was strictly adhered to.

Questions about this trial

What is this clinical trial studying?

An observational study of Spinal Anesthesia and Cesarean Section, run by Cukurova University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of intra-operative hypotension (time frame: During surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in